Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Prss35 | Rat | 1,2-dichloroethane | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PRSS35 mRNA | CTD | PMID:28960355 | Prss35 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of PRSS35 mRNA | CTD | PMID:30723492 | Prss35 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of PRSS35 mRNA | CTD | PMID:12075121 | Prss35 | Rat | 17beta-estradiol | affects expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Estradiol affects the expression of PRSS35 mRNA | CTD | PMID:22574217 | Prss35 | Rat | 17beta-estradiol | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | Estradiol results in increased expression of PRSS35 mRNA | CTD | PMID:19484750 | Prss35 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of PRSS35 mRNA | CTD | PMID:19095052 | Prss35 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PRSS35 mRNA | CTD | PMID:19933214 | Prss35 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PRSS35 mRNA | CTD | PMID:33387578 | Prss35 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | decreases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | 2,2',4,4',5-brominated diphenyl ether results in decreased expression of PRSS35 mRNA | CTD | PMID:26705709 | Prss35 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | bisphenol S results in increased expression of PRSS35 mRNA | CTD | PMID:30951980 | Prss35 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Prss35 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of PRSS35 mRNA | CTD | PMID:24780913 | Prss35 | Rat | all-trans-retinoic acid | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of PRSS35 mRNA | CTD | PMID:21934132 | Prss35 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of PRSS35 mRNA | CTD | PMID:38685447 | Prss35 | Rat | aristolochic acid A | multiple interactions | EXP | | 6480464 | [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of PRSS35 mRNA | CTD | PMID:23912714 | Prss35 | Rat | aristolochic acid A | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of PRSS35 mRNA | CTD | PMID:33212167 | Prss35 | Rat | arsenous acid | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of PRSS35 mRNA | CTD | PMID:35676786 | Prss35 | Rat | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of PRSS35 mRNA | CTD | PMID:21839799 | Prss35 | Rat | benzo[a]pyrene | affects methylation | ISO | PRSS35 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of PRSS35 promoter | CTD | PMID:27901495 | Prss35 | Rat | benzo[a]pyrene | increases methylation | ISO | PRSS35 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of PRSS35 5' UTR | CTD | PMID:27901495 | Prss35 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of PRSS35 mRNA | CTD | PMID:33754040 | Prss35 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PRSS35 mRNA | CTD | PMID:25181051 | Prss35 | Rat | bisphenol A | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of PRSS35 mRNA | CTD | PMID:32156529 | Prss35 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Prss35 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PRSS35 mRNA | CTD | PMID:30816183 | Prss35 | Rat | bisphenol F | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | bisphenol F results in increased expression of PRSS35 mRNA | CTD | PMID:30951980 | Prss35 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Prss35 | Rat | bisphenol F | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of PRSS35 mRNA | CTD | PMID:36706583 | Prss35 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PRSS35 mRNA | CTD | PMID:33453195 | Prss35 | Rat | cadmium dichloride | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of PRSS35 mRNA | CTD | PMID:38382870 | Prss35 | Rat | camptothecin | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of PRSS35 mRNA | CTD | PMID:38460933 | Prss35 | Rat | cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of PRSS35 mRNA | CTD | PMID:18500788 | Prss35 | Rat | CGP 52608 | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PRSS35 gene] | CTD | PMID:28238834 | Prss35 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of PRSS35 mRNA | CTD | PMID:27523638 | Prss35 | Rat | cytarabine | decreases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Cytarabine results in decreased expression of PRSS35 mRNA | CTD | PMID:21198554 | Prss35 | Rat | DDE | decreases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of PRSS35 mRNA | CTD | PMID:38568856 | Prss35 | Rat | diarsenic trioxide | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of PRSS35 mRNA | CTD | PMID:35676786 | Prss35 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of PRSS35 mRNA | CTD | PMID:21266533 | Prss35 | Rat | diquat | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | Diquat results in decreased expression of PRSS35 mRNA | CTD | PMID:36851058 | Prss35 | Rat | dorsomorphin | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Prss35 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of PRSS35 mRNA | CTD | PMID:29391264 | Prss35 | Rat | genistein | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | Genistein results in increased expression of PRSS35 mRNA | CTD | PMID:21810550 | Prss35 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of PRSS35 mRNA | CTD | PMID:33387578 | Prss35 | Rat | lipopolysaccharide | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PRSS35 mRNA | CTD | PMID:35811015 | Prss35 | Rat | methylmercury chloride | decreases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of PRSS35 mRNA | CTD | PMID:28001369 | Prss35 | Rat | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of PRSS35 mRNA | CTD | PMID:33484710 | Prss35 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of PRSS35 mRNA | CTD | PMID:37995155 | Prss35 | Rat | pirinixic acid | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Prss35 | Rat | propanal | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of PRSS35 mRNA | CTD | PMID:26079696 | Prss35 | Rat | resveratrol | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of PRSS35 mRNA | CTD | PMID:23557933 | Prss35 | Rat | rotenone | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Rotenone results in increased expression of PRSS35 protein | CTD | PMID:39603559 | Prss35 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PRSS35 mRNA | CTD | PMID:35811015 | Prss35 | Rat | SB 431542 | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Prss35 | Rat | silicon dioxide | decreases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of PRSS35 mRNA | CTD | PMID:25895662 | Prss35 | Rat | silicon dioxide | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of PRSS35 mRNA | CTD | PMID:19073995 | Prss35 | Rat | sodium arsenate | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of PRSS35 mRNA | CTD | PMID:21795629 | Prss35 | Rat | sodium arsenite | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of PRSS35 mRNA | CTD | PMID:38568856 | Prss35 | Rat | sodium arsenite | decreases expression | ISO | Prss35 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PRSS35 mRNA | CTD | PMID:37682722 | Prss35 | Rat | sunitinib | decreases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of PRSS35 mRNA | CTD | PMID:31533062 | Prss35 | Rat | temozolomide | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of PRSS35 mRNA | CTD | PMID:31758290 | Prss35 | Rat | titanium dioxide | increases expression | ISO | Prss35 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of PRSS35 mRNA | CTD | PMID:35295148 | Prss35 | Rat | trichostatin A | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of PRSS35 mRNA | CTD | PMID:24935251 | Prss35 | Rat | triticonazole | decreases expression | EXP | | 6480464 | triticonazole results in decreased expression of PRSS35 mRNA | CTD | PMID:36084822 | Prss35 | Rat | valproic acid | affects expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PRSS35 mRNA | CTD | PMID:25979313 | Prss35 | Rat | valproic acid | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PRSS35 mRNA | CTD | PMID:19101580|PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369 | Prss35 | Rat | valproic acid | multiple interactions | ISO | PRSS35 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Prss35 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of PRSS35 mRNA | CTD | PMID:20566332 | Prss35 | Rat | zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of PRSS35 mRNA | CTD | PMID:19111725 | Prss35 | Rat | zinc atom | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Zinc deficiency results in increased expression of PRSS35 mRNA] | CTD | PMID:19111725 | Prss35 | Rat | zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of PRSS35 mRNA | CTD | PMID:19111725 | Prss35 | Rat | zinc(0) | multiple interactions | EXP | | 6480464 | Zinc inhibits the reaction [Zinc deficiency results in increased expression of PRSS35 mRNA] | CTD | PMID:19111725 | Prss35 | Rat | zoledronic acid | increases expression | ISO | PRSS35 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of PRSS35 mRNA | CTD | PMID:24714768 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















